EyeGate Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. EyeGate Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 100% to $12,059. Profit margin reached -67103%. Total operating expenses were $8,224,814.
Profit Margin
| 2012 | 0 | -6.03M | |
|---|---|---|---|
| 2013 | 0 | -3.87M | |
| 2014 | 0 | -1.77M | |
| 2015 | 0 | -8.39M | |
| 2016 | 669.25K | -13.34M | -1993.76% |
| 2017 | 407.51K | -13.21M | -3243.52% |
| 2018 | 1.65M | -10.81M | -654.24% |
| 2019 | 2.68M | -7.09M | -264.21% |
| 2020 | 12.05K | -8.09M | -67102.91% |
EYEG Income Statement (2012 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 12.05K | 2.68M | 1.65M | 407.51K | 669.25K | 0 | 0 | 0 | 0 |
Cost of revenue | 12.04K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 13 | 2.68M | 1.65M | 407.51K | 669.25K | 0 | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 3.56M | 5.38M | 8.05M | 10.33M | 8.42M | 2.71M | 531.11K | 1.01M | 3.03M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 8.22M | 9.79M | 12.49M | 14.96M | 14.01M | 6.67M | 2.46M | 3.09M | 5.85M |
Operating income | -8.21M | -7.10M | -10.84M | -14.55M | -13.34M | -6.67M | -2.46M | -3.09M | -5.85M |
Other income (expenses), net | 132.87K | 107.74K | 119.32K | -651 | 3.40K | -1.71M | 910.57K | -584.68K | 43.87K |
Income before tax | -8.07M | -7.00M | -10.72M | -14.55M | -13.34M | -8.38M | -1.55M | -3.68M | -5.80M |
Income tax expense | 12.05K | 95.39K | 86.04K | -1.34M | 3.68K | 224.12K | 1.35M | 26.70K | 0 |
Net income | -8.09M | -7.09M | -10.81M | -13.21M | -13.34M | -8.39M | -1.77M | -3.87M | -6.03M |
Earnings per share | |||||||||
Basic EPS | -2.54 | -2.23 | -4.57 | -13.9 | -22.66 | -18.14 | -3.83 | -11.62 | -469.28 |
Diluted EPS | -2.54 | -2.23 | -4.57 | -13.9 | -22.66 | -18.14 | -3.83 | -11.62 | -469.28 |
| Data source | Data source | Data source | Data source | Data source | Data source |